TMCI

Treace Medical Concepts, Inc. Common Stock

4.03

USD

-0.15

-3.59%

Nov 06, 15:59 UTC -5

Closed

After-Market

4.04

+0.01

+0.25%

Treace Medical Concepts, Inc. Common Stock (TMCI) Earnings

TMCI Earnings Reports

Positive Surprise Ratio

TMCI beat 18 of 23 last estimates.

78%

Next Report

Date of Next Report

Feb 25, 2027

Estimate for Q4 26 (Revenue/ EPS)

$68.75M

-$0.07

Implied change from Q3 26 (Revenue/ EPS)

+42.48%

-63.16%

Implied change from Q4 25 (Revenue/ EPS)

+9.96%

-53.33%

Treace Medical Concepts, Inc. Common Stock earnings per share and revenue

On Nov 06, 2026, TMCI reported earnings of -0.19 USD per share (EPS) for Q3 26, beating the estimate of -0.25 USD, resulting in a 26.67% surprise. Revenue reached 48.25 million, compared to an expected 48.76 million, with a -1.04% difference. The market reacted with a -3.59% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of -0.07 USD, with revenue projected to reach 68.75 million USD, implying an decrease of -63.16% EPS, and increase of 42.48% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Tandem Diabetes Care, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.10

Surprise

+59.55%

Artivion, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.06

Actual

$0.08

Surprise

+228.00%

Mobia Medical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.04%

Inogen Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.56

Surprise

-285.41%

Envoy Medical, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.68

Actual

-$0.50

Surprise

+26.47%

Mettler-Toledo International

Report Date

Nov 05, 2026 For Q3 26

Estimate

$12.21

Actual

$12.57

Surprise

+2.90%

GLOBUS MEDICAL INC

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.22

Actual

$1.23

Surprise

+0.75%

Teleflex Incorporated

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.92

Actual

$2.63

Surprise

+36.82%

CVRx, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.52

Surprise

-2.91%

SiNtx Technologies, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.31

Actual

-$0.24

Surprise

+23.27%

FAQ

What were Treace Medical Concepts, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Treace Medical Concepts, Inc. Common Stock reported EPS of -$0.19, beating estimates by 26.67%, and revenue of $48.25M, -1.04% below expectations.

How did the market react to Treace Medical Concepts, Inc. Common Stock's Q3 2026 earnings?

The stock price moved down -3.59%, changed from $4.18 before the earnings release to $4.03 the day after.

When is Treace Medical Concepts, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 25, 2027.

What are the forecasts for Treace Medical Concepts, Inc. Common Stock's next earnings report?

Based on -- analysts, Treace Medical Concepts, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $68.75M for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.